The National Institute of Public Health (FHI) believes that the AstraZeneca vaccine should be dropped from the vaccination program. The government believes that there is not a good enough basis for making such a decision.
The vaccination with AstraZeneca vaccines was paused in Norway on March 11 after rare cases of blood clots, bleeding, and low levels of platelets were reported.
In Norway, researchers have examined five patients with severe symptoms. Four women and a man aged between 32 and 54 years all experienced different variants of the same disease. Three of them died. All three were health workers.
On Wednesday, Denmark became the first country to drop the AstraZeneca vaccine from its vaccination program.
The vaccination of everyone over the age of 50 in Denmark could be delayed by three weeks due to the decision.
EMA and WHO positions
Both the European Medicines Agency (EMA) and the World Health Organization (WHO) believe that the vaccine should be used because it has greater advantages than disadvantages.
Other European countries, including Germany and France, have decided that only people over a certain age should receive the vaccine.
Norway has around 180,600 AstraZeneca doses in stock. A total of 52,800 of them have an expiration date of June 30, while the rest expire on July 30.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at email@example.com